newsfilter
← Latest News
Business Wire·

Xencor Announces Pricing of $175 Million Public Offering of Common Stock

Xencor, Inc. ("Xencor") (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the pricing of its underwritten